These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27246502)

  • 1. Two approaches to the clinical dilemma of treating TTP with therapeutic plasma exchange in patients with a history of anaphylactic reactions to plasma.
    Sidhu D; Snyder EL; Tormey CA
    J Clin Apher; 2017 Jun; 32(3):158-162. PubMed ID: 27246502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of 50% albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura.
    O'Brien KL; Price TH; Howell C; Delaney M
    J Clin Apher; 2013 Dec; 28(6):416-21. PubMed ID: 23857424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.
    Stefanello B; De Paula EV; Andrade Orsi F; Comenalli Marques JF; Gasparotto Roveri E; Pereira Colella M; Castro Ozelo M; Maria Annichino-Bizzacchi J; Addas-Carvalho M
    J Clin Apher; 2014 Dec; 29(6):311-5. PubMed ID: 24890787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
    Pandey S; Nakagawa M; Rosenbaum ER; Arnaoutakis K; Hutchins LF; Makhoul I; Milojkovic N; Cottler-Fox M
    J Clin Apher; 2015 Feb; 30(1):50-4. PubMed ID: 25042026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic plasma exchange for thrombotic thrombocytopenic purpura with refractory thrombocytopenia.
    Maloney N; Martin I; Szczepiorkowski ZM; Dunbar NM
    J Clin Apher; 2018 Jun; 33(3):436-438. PubMed ID: 29270999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid ADAMTS13 availability impacts treatment for microangiopathic hemolytic anemia and thrombocytopenia.
    Martin IW; Katus MC; Martin CL; Szczepiorkowski ZM; Gorham JD; Dunbar NM
    J Clin Apher; 2016 Oct; 31(5):419-22. PubMed ID: 26332753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B
    Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity to plasma exchange in a patient with thrombotic thrombocytopenic purpura.
    Lalmuanpuii J; Yalamanchili K; Fircanis S; Nelson JC
    J Clin Apher; 2009; 24(1):18-20. PubMed ID: 19073012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of allergic reactions with fresh frozen plasma or cryo-supernatant plasma in the treatment of thrombotic thrombocytopenic purpura.
    Reutter JC; Sanders KF; Brecher ME; Jones HG; Bandarenko N
    J Clin Apher; 2001; 16(3):134-8. PubMed ID: 11746540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Altuntas F; Aydogdu I; Kabukcu S; Kocyigit I; Cikim K; Sari I; Erkut MA; Eser B; Ozturk A; Kaya E; Cetin M; Keskin A; Unal A
    Transfus Apher Sci; 2007 Feb; 36(1):57-67. PubMed ID: 17240195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
    Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura.
    Connell NT; Cheves T; Sweeney JD
    Transfusion; 2016 Feb; 56(2):354-9. PubMed ID: 26456149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma therapy in thrombotic thrombocytopenic purpura: review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency.
    Fontana S; Kremer Hovinga JA; Studt JD; Alberio L; Lämmle B; Taleghani BM
    Semin Hematol; 2004 Jan; 41(1):48-59. PubMed ID: 14727259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura.
    Moore JC; Arnold DM; Leber BF; Clare R; Molnar GJ; Kelton JG
    Vox Sang; 2007 Aug; 93(2):173-5. PubMed ID: 17683362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
    Moake JL
    Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and laboratory findings of thrombotic thrombocytopenic purpura associated with ticlopidine].
    Yagi H
    Rinsho Byori; 2005 Jul; 53(7):630-8. PubMed ID: 16104532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of thrombotic thrombocytopenic purpura.
    Fontana S; Kremer Hovinga JA; Lämmle B; Mansouri Taleghani B
    Vox Sang; 2006 May; 90(4):245-54. PubMed ID: 16635066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic thrombocytopenic purpura: The role of ADAMTS13.
    Rogers HJ; Allen C; Lichtin AE
    Cleve Clin J Med; 2016 Aug; 83(8):597-603. PubMed ID: 27505881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.